RCC diagnosed incident cases to reach 230,000 in 8MM by 2033: GlobalData GlobalData Jul 25, 2024 According to GlobalData epidemiologists, there were 19.90 per cent of stage III diagnosed incident cases of RCC and 17.90 per cent…
DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma EP News Bureau Oct 26, 2023 KEYTRUDA is now approved for 14 indications across eight tumour types in India
